ciglitazone and u 0126

ciglitazone has been researched along with u 0126 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, F; Harrison, LE; Kim, E; Wang, CC1
Chae, JJ; Chang, HK; Kim, DS; Kim, M; Lee, KH; Lee, MW; Myong, JP; Park, TC1

Other Studies

2 other study(ies) available for ciglitazone and u 0126

ArticleYear
Ciglitazone-induced p27 gene transcriptional activity is mediated through Sp1 and is negatively regulated by the MAPK signaling pathway.
    Cellular signalling, 2005, Volume: 17, Issue:12

    Topics: Binding Sites; Butadienes; Cyclin-Dependent Kinase Inhibitor p27; Flavonoids; Gene Expression Regulation; HT29 Cells; Humans; Luciferases; MAP Kinase Signaling System; Nitriles; Phosphorylation; Plicamycin; Promoter Regions, Genetic; Sp1 Transcription Factor; Thiazolidinediones; Time Factors; Transcription, Genetic; Transfection

2005
Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor γ (PPARγ) agonists in HeLa cells.
    Biochemical and biophysical research communications, 2017, Jan-22, Volume: 482, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Butadienes; Caspase 3; Cell Survival; Cervix Uteri; Chromans; Drug Synergism; Enzyme Inhibitors; Female; HeLa Cells; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitriles; PPAR gamma; Thiazolidinediones; Troglitazone; Uterine Cervical Neoplasms

2017